Porovnať metódy

	MSFC: Funkčný kompozit pre roztrúsenú sklerózu	NIHSS: National Institutes of Health Stroke Scale	RMI: Rivermead Mobility Index
Odbor	Neurológia	Neurológia	Neurológia
Rodina	Process / pipeline	Process / pipeline	Process / pipeline
Rok vzniku	1999	1989	1991
Tvorca	Gary Cutter, Richard Rudick, and NMSS Consortium	Thomas Brott and NIH Stroke Study Group	Frank Collen, Derick Wade, and Rivermead Rehabilitation Centre
Typ	Clinician-administered performance test	Clinician-rated	Clinician-observed performance test
Pôvodný zdroj	Cutter, G. R., Baier, M. L., Rudick, R. A., et al. (1999). Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Multiple Sclerosis, 5(4), 244-250.	Brott, T., Adams, H. P., Olinger, C. P., et al. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864-870.	Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54.
Ďalšie názvy	MS Functional Composite	NIH Stroke Scale	Rivermead Mobility Index
Príbuzné	4	5	5
Zhrnutie	The Multiple Sclerosis Functional Composite (MSFC) is an objective, performance-based assessment of MS-related disability capturing three key functional domains: lower extremity mobility, upper extremity coordination, and cognitive/processing speed. Developed in 1999 by the National MS Society and adopted widely in clinical trials, the MSFC provides quantifiable endpoints complementing the Expanded Disability Status Scale (EDSS). The three-component design addresses EDSS limitations by including cognition and standardizing measurement via timed tasks.	The NIHSS is the standard acute stroke severity assessment tool used in emergency departments, stroke centers, and clinical trials worldwide. Developed by the NIH Stroke Study Group in 1989, the 15-item scale provides rapid, reproducible quantification of acute neurological deficit from ischemic or hemorrhagic stroke. NIHSS scores inform thrombolytic and thrombectomy eligibility, predict outcomes, and serve as primary endpoint in stroke intervention trials.	The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes.